Insider: Yea Christopher CHIEF DEVELOPMENT OFFICER - KalVista Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 132,052 | 0 | 132,052 |
| Value | $1,637,444.80 | $0.00 | $1,637,444.80 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/25/2025 | DDS | 1,954 | Direct | COM | $13.42 | $26,222.68 | 132,052 |
| 08/22/2025 | DDS | 2,362 | Direct | COM | $13.22 | $31,232.25 | 130,881 |
| 08/18/2025 | DDS | 2,649 | Direct | COM | $13.19 | $34,932.36 | 129,493 |
| 07/09/2025 | DDS | 30,250 | Direct | COM | $15.69 | $474,698.13 | 127,939 |
| 05/23/2025 | DDS | 1,926 | Direct | COM | $11.31 | $21,781.71 | 98,189 |
| 05/22/2025 | DDS | 2,317 | Direct | COM | $11.88 | $27,515.53 | 96,990 |
| 05/19/2025 | DDS | 2,600 | Direct | COM | $11.84 | $30,791.28 | 95,557 |
| 02/24/2025 | DDS | 1,918 | Direct | COM | $10.02 | $19,218.36 | 93,952 |
| 02/18/2025 | DDS | 2,601 | Direct | COM | $9.82 | $25,552.74 | 92,745 |
| 11/26/2024 | DDS | 1,963 | Direct | COM | $9.87 | $19,378.34 | 91,142 |
| 11/18/2024 | DDS | 7,192 | Direct | COM | $9.26 | $66,572.75 | 89,980 |
| 08/23/2024 | DDS | 1,916 | Direct | COM | $12.40 | $23,758.40 | 85,676 |
| 08/19/2024 | DDS | 7,102 | Direct | COM | $12.01 | $85,318.46 | 84,467 |
| 05/20/2024 | DDS | 11,610 | Direct | COM | $11.76 | $136,585.85 | 80,074 |
| 02/20/2024 | DDS | 12,053 | Direct | COM | $14.11 | $170,124.48 | 72,895 |
| 02/14/2024 | DDS | 39,886 | Direct | COM | $15.01 | $598,660.94 | 66,160 |
| 11/20/2023 | DDS | 7,113 | Direct | COM | $8.23 | $58,535.01 | 46,046 |
| 08/18/2023 | DDS | 7,142 | Direct | COM | $10.73 | $76,624.38 | 41,662 |
| 05/18/2023 | DDS | 2,604 | Direct | COM | $10.14 | $26,416.02 | 37,310 |
| 11/18/2022 | DDS | 1,139 | Direct | COM | $5.44 | $6,196.16 | 34,232 |
| 08/17/2022 | DDS | 1,145 | Direct | COM | $14.96 | $17,130.00 | 33,597 |
| 11/01/2021 | DDS | 5,000 | Direct | COM | $18.07 | $90,328.00 | 32,969 |
| 08/02/2021 | DDS | 5,000 | Direct | COM | $20.52 | $102,578.50 | 37,969 |
| 05/03/2021 | DDS | 5,000 | Direct | COM | $24.84 | $124,196.50 | 42,969 |
| 02/23/2021 | DDS | 10,389 | Direct | COM | $33.74 | $350,571.61 | 51,780 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research